104 related articles for article (PubMed ID: 31477553)
1. Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes.
Hermans MP; Ahn SA; Rousseau MF
J Diabetes Complications; 2019 Nov; 33(11):107413. PubMed ID: 31477553
[TBL] [Abstract][Full Text] [Related]
2. Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM.
Hermans MP; Amoussou-Guenou KD; Bouenizabila E; Sadikot SS; Ahn SA; Rousseau MF
Diabetes Metab Syndr; 2017; 11(2):125-131. PubMed ID: 27665027
[TBL] [Abstract][Full Text] [Related]
3. High rates of atherogenic dyslipidemia, β-cell function loss, and microangiopathy among Turkish migrants with T2DM.
Hermans MP; Ahn SA; Sadikot S; Rousseau MF
Diabetes Metab Syndr; 2019; 13(1):716-720. PubMed ID: 30641794
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
[TBL] [Abstract][Full Text] [Related]
5. Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control.
Fronczyk A; Molęda P; Safranow K; Piechota W; Majkowska L
Inflammation; 2014 Apr; 37(2):349-57. PubMed ID: 24197824
[TBL] [Abstract][Full Text] [Related]
6. Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy.
Gong YY; Peng HY
Lipids Health Dis; 2021 Mar; 20(1):25. PubMed ID: 33722242
[TBL] [Abstract][Full Text] [Related]
7. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
Streja D; Cressey P; Rabkin SW
J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
[TBL] [Abstract][Full Text] [Related]
8. [HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.
Hermans MP; Valensi P; Ahn SA; Rousseau MF
Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28921828
[TBL] [Abstract][Full Text] [Related]
9. Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.
Hermans MP; Ahn SA; Sadikot S; Rousseau MF
Diabetes Metab Syndr; 2020; 14(5):1503-1509. PubMed ID: 32795742
[TBL] [Abstract][Full Text] [Related]
10. Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring.
Hermans MP; Ahn SA; Rousseau MF
J Diabetes; 2019 Apr; 11(4):301-308. PubMed ID: 30105804
[TBL] [Abstract][Full Text] [Related]
11. Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?
Hermans MP; Ahn SA; Amoussou-Guenou KD; Balde NM; Rousseau MF
Diabet Med; 2010 Apr; 27(4):417-22. PubMed ID: 20536513
[TBL] [Abstract][Full Text] [Related]
12. The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females.
Hermans MP; Ahn SA; Rousseau MF
Lipids Health Dis; 2012 Oct; 11():132. PubMed ID: 23046637
[TBL] [Abstract][Full Text] [Related]
13. The normal-weight type 2 diabetes phenotype revisited.
Hermans MP; Amoussou-Guenou KD; Bouenizabila E; Sadikot SS; Ahn SA; Rousseau MF
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S82-8. PubMed ID: 26960924
[TBL] [Abstract][Full Text] [Related]
14. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study.
Aryan Z; Ghajar A; Faghihi-Kashani S; Afarideh M; Nakhjavani M; Esteghamati A
Ann Nutr Metab; 2018; 72(4):287-295. PubMed ID: 29694948
[TBL] [Abstract][Full Text] [Related]
15. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.
Qasim AN; Budharaju V; Mehta NN; St Clair C; Farouk S; Braunstein S; Schutta M; Iqbal N; Rader DJ; Reilly MP
Clin Endocrinol (Oxf); 2011 Jan; 74(1):44-50. PubMed ID: 20874770
[TBL] [Abstract][Full Text] [Related]
17. Classical and emergent cardiovascular disease risk factors in type 2 diabetics from the Vallecas area (DICARIVA study).
García-Quismondo Á; Del Cañizo FJ; Dorado J; Sánchez-Muniz FJ
Nutr Hosp; 2017 Nov; 34(5):1432-1441. PubMed ID: 29280661
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk evaluated by C-reactive protein levels in diabetic and obese Mexican subjects.
Flores-Alfaro E; Parra-Rojas I; Salgado-Bernabé AB; Chávez-Maldonado JP; Salazar-Martinez E
Circ J; 2008 Jul; 72(7):1170-4. PubMed ID: 18577830
[TBL] [Abstract][Full Text] [Related]
19. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
[TBL] [Abstract][Full Text] [Related]
20. The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetes.
Hermans MP; Ahn SA; Rousseau MF
J Diabetes Complications; 2012; 26(3):187-94. PubMed ID: 22521319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
